Summary
Updated Aug 30, 2026
Samit Hirawat is Director of Pacira BioSciences, Inc. (PCRX). 3 SEC Form 4 filings on record going back to 2024, most recently on 13 June 2026. Most recent open-market trade: bought $100K of BMY on 5 November 2024. Lifetime open-market purchases: $100K.
Recent Transactions
2Every recent SEC Form 4 transaction Samit Hirawat has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Samit Hirawat files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shawn Cross - $895K of PCRX open-market activity in the last 12 months
- Kristen Williams - $498K of PCRX open-market activity in the last 12 months
- Jonathan Slonin - $240K of PCRX open-market activity in the last 12 months
- Lauren Riker - $227K of PCRX open-market activity in the last 12 months
- Abraham Ceesay - $64K of PCRX open-market activity in the last 12 months
- Mark Froimson - $11K of PCRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Samit Hirawat?
Samit Hirawat is a corporate insider, tracked as Director of Pacira BioSciences, Inc. (PCRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Samit Hirawat submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Samit Hirawat been buying or selling stock?
Recorded transactions: 1 open-market purchase ($100K) and 0 open-market sales across all tracked filings.
Where can I see all of Samit Hirawat's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Samit Hirawat and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
